SPGP's selection offers a mix of low P/E ratios, positive EPS CAGR, and competitive ROE. Read more on why SPGP may not be the ...

The business in question that sells at a cheap valuation is Target ( TGT -0.47%). With $23.8 billion in revenue in ...

Palantir stock has risen by 85% so far this year, making it the top-performing company in the S&P 500 and Nasdaq-100.

Several basic guidelines can help you compare investment properties. Ideally, a comprehensive analysis would consider every ...

Investors are betting that a slew of long-sought policy wins for the industry, expected next week, could invite new investment in the asset class.

President Donald Trump announced a new set of duties on Canadian goods that were not covered by existing sectoral tariffs.

Something different just happened to the U.S. dollar, which recently completed its worst first half of any calendar year since at least the 1970s: The dollar strengthened this week, despite President ...

The stock market has had a historic rally from its April 7 low. Since that time, the S&P 500 has rallied strongly to achieve new record highs. This up leg has climbed a wall of worry that has included ...

Bitcoin’s explosive growth continues to outshine gold, stocks, and the dollar, with 100% of trading days profitable resulting ...

New law ends EV mandates, cutting costs for gas cars and impacting EV sales. Discover how this impacts automakers like Tesla, ...

International stocks have outpaced the S&P 500 so far this year-just one reason why you should consider diversifying geographically.

The Food and Drug Administration (FDA) can maintain its high bar for safety and efficacy, and also cut the waste and unnecessary delays in the regulatory process.